Product image of Kalymin (Pyridostigmine Bromide) supplied by GNH India

Kalymin

Active Ingredient:
Pyridostigmine Bromide
Origin:
EU

Kalymin (Pyridostigmine Bromide)

Pyridostigmine bromide, the active ingredient in Kalymin, is a cholinesterase inhibitor presented as an oral tablet for oral use. It is employed to improve muscle strength in myasthenia gravis and to reverse the effects of non‑depolarizing neuromuscular blocking agents.
GNH India supplies Kalymin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hormosan Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pyridostigmine bromide is used in conditions that involve impaired neuromuscular transmission.

  • Myasthenia gravis: enhances skeletal muscle strength by increasing acetylcholine availability.
  • Reversal of neuromuscular blockade: restores normal neuromuscular function after administration of non‑depolarizing blockers.
  • Myasthenic crisis: provides supportive therapy to improve respiratory muscle performance during acute exacerbations.

How It Works

  • Pyridostigmine bromide reversibly inhibits acetylcholinesterase at the neuromuscular junction, preventing the breakdown of acetylcholine. The resulting increase in acetylcholine concentration enhances stimulation of nicotinic receptors on skeletal muscle, thereby improving muscle contraction and counteracting the effects of neuromuscular blocking agents.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: increased bowel movements.
  • Abdominal cramps: discomfort in the stomach area.
  • Increased salivation: excess oral secretions.
  • Sweating: heightened perspiration.
  • Muscle cramps: involuntary muscle tightening.

Serious or Rare Side Effects

  • Cholinergic crisis: severe muscle weakness and respiratory failure.
  • Bradycardia: markedly slow heart rate.
  • Bronchospasm: narrowing of the airways causing breathing difficulty.
  • Seizures: uncontrolled electrical activity in the brain.
  • Anaphylaxis: life‑threatening allergic reaction.

Precautions & Warnings

Before prescribing pyridostigmine bromide, clinicians should consider several safety measures.

  • Renal impairment: adjust dose because the drug is renally excreted.
  • Asthma or COPD: monitor for bronchospasm due to cholinergic effects.
  • Cardiac conditions: observe for bradycardia or heart block.
  • Concomitant anticholinergic therapy: may reduce efficacy, requiring dose review.
  • Known hypersensitivity: avoid use if allergic reactions have occurred.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Pyridostigmine bromide can alter the activity of several other medicines.

Major Interactions (Avoid)

  • Non‑depolarizing neuromuscular blockers: may potentiate blockade, risking prolonged paralysis.
  • Other cholinesterase inhibitors: can cause excessive cholinergic activity.
  • Beta‑blockers: increase risk of bradycardia and hypotension.

Moderate Interactions (Monitor Closely)

  • Anticholinergic drugs (e.g., atropine): may diminish therapeutic effect.
  • Diuretics that cause hypokalemia: can exacerbate muscle weakness.
  • Magnesium supplements: may enhance neuromuscular blockade.

Frequently Asked Questions

Kalymin contains pyridostigmine bromide, which is prescribed to improve muscle strength in patients with myasthenia gravis and to reverse the effects of non‑depolarizing neuromuscular blocking agents after surgery or anesthesia.

The drug reversibly inhibits the enzyme acetylcholinesterase at the neuromuscular junction, preventing the breakdown of acetylcholine. This increases the amount of acetylcholine available to stimulate muscle receptors, enhancing contraction and counteracting weakness.

The appropriate dose of Kalymin is determined by the prescribing clinician based on the individual’s condition, severity, renal function, and response to therapy. Patients should follow the exact dosing instructions provided by their healthcare professional.

The safety of pyridostigmine bromide in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To request Kalymin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Kalymin (pyridostigmine bromide) is a reversible, peripherally acting cholinesterase inhibitor, similar to neostigmine but with a longer duration of action and fewer central nervous system effects. Choice of agent depends on clinical context, dosing convenience, and patient tolerance.

Kalymin should be stored at ambient temperature, below 25 °C, in its original packaging. It must be kept away from moisture and direct sunlight to maintain stability and potency.

Kalymin is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact administration schedule is individualized based on therapeutic response and tolerability.

The most serious risks include cholinergic crisis, which can cause severe muscle weakness and respiratory failure, as well as marked bradycardia, bronchospasm, and rare allergic reactions such as anaphylaxis. Prompt medical attention is required if these occur.

Kalymin should be avoided in individuals with known hypersensitivity to pyridostigmine bromide or other cholinesterase inhibitors, and used with caution in patients with severe asthma, cardiac conduction disorders, or significant renal impairment unless dose adjustments are made.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pyridostigmine Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT